New Research Report on China Olanzapine Market Growth, 2010-2019
<str<strong>on</strong>g>New</str<strong>on</strong>g> <str<strong>on</strong>g>Research</str<strong>on</strong>g> <str<strong>on</strong>g>Report</str<strong>on</strong>g> <strong>on</strong> <strong>China</strong> <strong>Olanzapine</strong> <strong>Market</strong> <strong>Growth</strong>, <strong>2010</strong>-<strong>2019</strong><br />
"The <str<strong>on</strong>g>Report</str<strong>on</strong>g> Investigati<strong>on</strong> <str<strong>on</strong>g>Report</str<strong>on</strong>g> <strong>on</strong> <strong>China</strong> <strong>Olanzapine</strong> <strong>Market</strong>, <strong>2010</strong>-<strong>2019</strong> provides informati<strong>on</strong><br />
<strong>on</strong> pricing, market analysis, shares, forecast, and company profiles for key industry participants.<br />
- <strong>Market</strong><str<strong>on</strong>g>Research</str<strong>on</strong>g><str<strong>on</strong>g>Report</str<strong>on</strong>g>s.biz"<br />
Descripti<strong>on</strong><br />
According to WHO’s statistics, at least 10% of world populati<strong>on</strong> suffer from various kinds of<br />
mental illnesses. According to the statistics published by the Nati<strong>on</strong>al Center for Mental Health,<br />
<strong>China</strong>-CDC, the number of cases of mental illnesses is more than 100 milli<strong>on</strong>, am<strong>on</strong>g which 16<br />
milli<strong>on</strong> suffer from holergasia. Mental illness has surpassed cancer and become the biggest threat to<br />
human health, ranking first in the total burden of disease in <strong>China</strong>.<br />
View Full <str<strong>on</strong>g>Report</str<strong>on</strong>g> at: http://www.marketresearchreports.biz/analysis/294875<br />
As an atypical antipsychotic, olanzapine is mainly used for the treatment of the positive symtoms of<br />
schizophrenia and it also has some curative effects <strong>on</strong> schizophrenia’s negative symtoms.<br />
Developed <strong>on</strong> the base of clozapine, the former generati<strong>on</strong> of antipsychotic medicati<strong>on</strong>, olanzapine<br />
was approved by Food and Drug Administrati<strong>on</strong> (FDA) to go <strong>on</strong> sale in 1996 and its patent held by<br />
Eli Lilly expired in 2011. The preparati<strong>on</strong>s of olanzapine available in mainland <strong>China</strong> include<br />
domestic Oulaining, Ximin and imported Zyperxa.<br />
As a drug for schizophrenia, olanzapine entered the European and American market in 1996 and<br />
then the Chinese market in 1999. In 2003, it was even rated as the first-line drug in the Guidelines<br />
for Preventi<strong>on</strong> and C<strong>on</strong>trol of Schizophrenia. <strong>Olanzapine</strong> develops fast after entering <strong>China</strong>, annual<br />
sales value rising from less than CNY 40 milli<strong>on</strong> in 2005 to CNY 420 milli<strong>on</strong> in 2014 and CAGR<br />
during this period reaching 30%. Hans<strong>on</strong> Pharmaceutical, Changzhou Wats<strong>on</strong> Pharmaceuticals Co.,<br />
Ltd and Eli Lilly and Company occupy the major market share, am<strong>on</strong>g which Hans<strong>on</strong><br />
Pharmaceutical has the largest market share of about 44% for sales value in 2014.<br />
With the change of life styles and the increased stress in work and life brought about by <strong>China</strong>’s<br />
ec<strong>on</strong>omic development, the incidence of mental illness and psychological problems is growing.<br />
Therefore, the market size of olanzapine in <strong>China</strong> is expected to keep expanding in the next few<br />
years.<br />
Download Detail <str<strong>on</strong>g>Report</str<strong>on</strong>g> With Complete TOC at:<br />
http://www.marketresearchreports.biz/sample/sample/294875
Readers can get at least the following informati<strong>on</strong> from this report:<br />
market size of olanzapine in <strong>China</strong><br />
competitive landscape of olanzapine in Chinese market<br />
price of olanzapine made by different enterprises in <strong>China</strong><br />
market outlook of olanzapine in <strong>China</strong><br />
The author suggests the following groups of people purchase this report:<br />
manufacturers of antipsychotics<br />
investors/ research instituti<strong>on</strong>s interested in Chinese medicine market<br />
any interest in the Chinese medicine market, please c<strong>on</strong>tact CRI for customized survey service<br />
Browse all latest Articles of <strong>Market</strong> <str<strong>on</strong>g>Research</str<strong>on</strong>g> <str<strong>on</strong>g>Report</str<strong>on</strong>g>s<br />
at:http://www.marketresearchreports.biz/articles<br />
About us<br />
<strong>Market</strong><str<strong>on</strong>g>Research</str<strong>on</strong>g><str<strong>on</strong>g>Report</str<strong>on</strong>g>s.biz is the most comprehensive collecti<strong>on</strong> of market research reports.<br />
<strong>Market</strong><str<strong>on</strong>g>Research</str<strong>on</strong>g><str<strong>on</strong>g>Report</str<strong>on</strong>g>s.Biz services are specially designed to save time and m<strong>on</strong>ey for our clients.<br />
We are a <strong>on</strong>e stop soluti<strong>on</strong> for all your research needs, our main offerings are syndicated research<br />
reports, custom research, subscripti<strong>on</strong> access and c<strong>on</strong>sulting services. We serve all sizes and types<br />
of companies spanning across various industries.<br />
Browse Our Press Releases by Prnewswire:<br />
http://www.prnewswire.com/news/marketresearchreports.biz<br />
Browse More PressRelease:<br />
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz<br />
C<strong>on</strong>tact<br />
Mr. Nachiket<br />
90 Sate Street, Suite 700<br />
Albany, NY 12207<br />
Tel: +1-518-621-2074<br />
Website: http://www.marketresearchreports.biz/<br />
E: sales@marketresearchreports.biz
Change language